Topic: metabolic syndrome
In mouse models of obesity, the naturally occurring protein FGFBP3 drastically reduced fat mass.
Targeting a protein called sarcolipin could prompt the body to burn more fat, researchers suggest in a new study.
Scientists at American University have discovered a potential method for treating obesity.
California researchers have gained insight into how a 30-year-old asthma drug called amlexanox helps burn calories—and it all ties into inflammation.
The deal gives Boehringer access to Gubra’s expertise in the design, synthesis and preclinical testing of therapeutic peptides.
Harvard University researchers have identified an enzyme that protects cells from harmful fats, which could inform new obesity treatments.
Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.